Connecting Innovation to Purpose

29 The obesity landscape is evolving to address these issues IM Muscle loss: Degree of weight loss → Quality of weight loss Tolerability: Single MOA → Multiple orthogonal MOAS Accessibility: Injectables → Oral small molecules

View entire presentation